Suppr超能文献

肾移植患者胸导管淋巴引流

Drainage of thoracic duct lymph in renal transplant patients.

作者信息

Franksson C, Lundgren G, Magnusson G, Ringdén O

出版信息

Transplantation. 1976 Feb;21(2):133-40. doi: 10.1097/00007890-197602000-00008.

Abstract

Lymphocyte depletion by drainage of lymph via a thoracic duct fistula was accomplished in 51 renal transplant recipients as an adjunct method for immunosuppression. The duration of lymph flow varied between 2 and 53 days and the total drained lymph volume between 1 and 168 liters. The graft survival of these patients was compared to that of a control group of patients undergoing transplantation during a similar period. The followup period was 2-6 years. In patients receiving transplants from living related donors, no beneficial effect of lymphocyte depletion was demonstrated, probably because of the satisfactory graft survival among the control patients (84% at 1 year). However, in recipients of cadaveric kidneys, a significantly higher 1-year graft survival was achieved in the lymph-drained patients. Drainage for more than 30 days and of more than 20 liters improved the results. Additional suppression by thymectomy and institution of antilymphocyte globulin suggested that the best treatment would be a combination of both these measures with lymph drainage continuing for more than 30 days. Infection around the thoracic duct cannula occurred in 5 patients, necessitating removal of the cannula in 2. Two patients developed septicemia. In one of them the infection originated from an infected incisional wound and in the other probably from reinfusion of contaminated lymph plasma. Two other patients developed malignant tumors 23 and 58 months after transplantation, respectively. It is felt that lymphocyte depletion by lymph drainage is an effective supplementary method of immunosuppression to enhance graft survival in recipients of cadaveric renal transplants.

摘要

通过胸导管瘘引流淋巴液使淋巴细胞减少,这一方法在51例肾移植受者中作为免疫抑制的辅助手段得以实施。淋巴液引流持续时间在2至53天之间,引流的淋巴液总量在1至168升之间。将这些患者的移植物存活率与同期接受移植的对照组患者进行比较。随访期为2至6年。在接受活体亲属供肾移植的患者中,未显示淋巴细胞减少有有益效果,这可能是因为对照组患者的移植物存活率令人满意(1年时为84%)。然而,在接受尸体肾移植的患者中,淋巴液引流患者1年移植物存活率显著更高。引流超过30天且引流液超过20升可改善结果。胸腺切除术及使用抗淋巴细胞球蛋白进行额外抑制表明,最佳治疗方法是将这两种措施与持续超过30天的淋巴液引流相结合。5例患者发生胸导管插管周围感染,其中2例需要拔除插管。2例患者发生败血症。其中1例感染源于感染的手术切口,另1例可能源于受污染淋巴血浆的回输。另外2例患者分别在移植后23个月和58个月发生恶性肿瘤。据认为,通过淋巴液引流使淋巴细胞减少是一种有效的免疫抑制辅助方法,可提高尸体肾移植受者的移植物存活率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验